Cysteo

Cysteo™ is an advanced depigmenting treatment formulated to address stubborn pigmentation concerns such as melasma, dark spots and post-inflammatory hyperpigmentation. Available at EDerma, founded by Dr Nivana Ramlachan, Cysteo™ offers a dermatologist-recommended, science-backed alternative to traditional pigment treatments. Powered by 5% cysteamine hydrochloride, this innovative topical cream works by regulating melanin production at its source, helping to visibly improve skin tone, clarity and radiance over time.

Unlike hydroquinone-based treatments, Cysteo™ is hydroquinone-free, non-carcinogenic and suitable for long-term use, making it an excellent option for ongoing pigmentation management. Its antioxidant properties help protect the skin from oxidative stress while supporting the skin barrier with nourishing ingredients such as vitamin E. This makes Cysteo™ suitable for all skin types, including sensitive and reactive skin.

Cysteo™ is applied once daily in the evening to clean, dry skin and left on for 15 minutes before rinsing off. With consistent use, skin appears more even-toned, luminous and refined. As pigmentation is often triggered or worsened by UV exposure, daily use of a broad-spectrum sunscreen is essential when using this treatment. Under the expert curation of EDerma, Cysteo™ offers a well-tolerated, effective solution for those seeking visible pigmentation correction with professional confidence.